【结 构 式】 |
【药物名称】Bepotastine besilate, Betotastine besilate, TAU-284DS, TAU-284, Talion 【化学名称】(+)-(S)-4-[4-[1-(4-Chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid monobenzenesulfonate 【CA登记号】190786-44-8, 190786-43-7 (free base), 125602-71-3 (free base undefined isomer) 【 分 子 式 】C27H31ClN2O6S 【 分 子 量 】547.07492 |
【开发单位】Ube (Originator), Senju (Licensee), Tanabe Seiyaku (Licensee) 【药理作用】Allergic Skin Disorders, Treatment for, Antiallergic Ophthalmic Agents, DERMATOLOGIC DRUGS, Drugs for Allergic Rhinitis, Ocular Antiinflammatory and Antiinfective Agents, OCULAR MEDICATIONS, Ophthalmic Drugs, RESPIRATORY DRUGS, Treatment of Upper Respiratory Tract Disorders, Urticaria, Treatment for, Histamine H1 Antagonists |
合成路线1
The reaction of 4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidine (I) with ethyl 4-bromobutyrate (II) by means of K2CO3 in refluxing acetone gives the corresponding condensation product (III), which is then hydrolyzed with NaOH in ethanol/water yielding compound (IV).
【1】 Castaner, J.; Graul, A.; Betotastine besilate. Drugs Fut 1998, 23, 3, 256. |
【2】 Koda, A.; Kuroki, Y.; Fujiwara, H.; Takamura, S.; Yamano, K. (Ube Industries, Ltd.); Piperidine and piperazine derivs., process for preparing the same and pharmaceutical compsns. containing them. EP 0335586; JP 1989242574; JP 1990025465; JP 1993294929; US 4929618 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16053 | 2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]pyridine; (4-chlorophenyl)(2-pyridinyl)methyl 4-piperidinyl ether | C17H19ClN2O | 详情 | 详情 | |
(II) | 11263 | ethyl 4-bromobutanoate; Ethyl 4-bromobutyrate | 2969-81-5 | C6H11BrO2 | 详情 | 详情 |
(III) | 16055 | ethyl 4-[4-[(4-chlorophenyl)(2-pyridinyl)methoxy]piperidino]butanoate | C23H29ClN2O3 | 详情 | 详情 | |
(IV) | 16056 | 4-[4-[(4-chlorophenyl)(2-pyridinyl)methoxy]piperidino]butyric acid | C21H25ClN2O3 | 详情 | 详情 |
合成路线2
A new synthesis of betotastine has been developed: The racemic 4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidine (I) is submitted to optical resolution with N-acyl amino acids such as N-acetyl-L-phenylalanine (preferred), N-acetyl-L-leucine, N-(benzyloxycarbonyl)-L-phenylalanine, N-(benzyloxycarbonyl)-L-valine, N-(benzyloxycarbonyl)-L-threonine, N-(benzyloxycarbonyl)-L-serine or with (2R,3R)-3-(5-chloro-2-nitrophenylsulfanyl)-2-hydroxy-3-(4-methoxyphenyl)propionic acid (preferred) or (2R,3R)-2-hydroxy-3-(4-methoxyphenyl)-3-(2-nitrophenylsulfanyl)propionic acid as chiral intermediates, yielding the (S)-isomer (II). The condensation of (II) with ethyl 4-bromobutyrate (III) by means of a base such as Na2CO3, NaHCO3, K2CO3 or KHCO3 gives the expected 4-(1-piperidinyl)butyric acid ester (IV), which is finally hydrolyzed with NaOH or KOH in aqueous ethanol or methanol.
【1】 Kita, J.; Yoshioka, R.; Ozaki, Y.; Takemura, S.; Fujiwara, H.; Yamada, S. (Tanabe Seiyaku Co., Ltd.; Ube Industries, Ltd.); Acid-addition salts of optically active piperidine cpd. and process for producing the same. JP 1998237070; JP 2000198784; WO 9829409 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16053 | 2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]pyridine; (4-chlorophenyl)(2-pyridinyl)methyl 4-piperidinyl ether | C17H19ClN2O | 详情 | 详情 | |
(II) | 22441 | (S)-(4-chlorophenyl)(2-pyridinyl)methyl 4-piperidinyl ether | C17H19ClN2O | 详情 | 详情 | |
(III) | 11263 | ethyl 4-bromobutanoate; Ethyl 4-bromobutyrate | 2969-81-5 | C6H11BrO2 | 详情 | 详情 |
(IV) | 22443 | ethyl 4-(4-[[(S)-(4-chlorophenyl)(2-pyridinyl)methyl]oxy]-1-piperidinyl)butanoate | C23H29ClN2O3 | 详情 | 详情 |
合成路线3
【1】 Ha TH, Parks CH, Kim WJ, et al. 2008. Process for preparing bepotastine and intermediates used therein. WO 2008153289 (Hanmi Pharm Co Ltd, S Korea). Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 67057 | (2R,5R)-2-isopropyl-5-methylcyclohexyl 4-(4-((S)-(4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate (R)-2-(((benzyloxy)carbonyl)amino)succinate | C31H43ClN2O3.C12H13NO6 | 详情 | 详情 | |
(I) | 11265 | 4-Chlorobutanoyl chloride; 4-Chlorobutyric acid chloride | 4635-59-0 | C4H6Cl2O | 详情 | 详情 |
(II) | 67053 | (1R,5R)-2-isopropyl-5-methylcyclohexanol | C10H20O | 详情 | 详情 | |
(III) | 67054 | (1S,5S)-2-isopropyl-5-methylcyclohexyl 4-chlorobutanoate | C14H25ClO2 | 详情 | 详情 | |
(IV) | 16053 | 2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]pyridine; (4-chlorophenyl)(2-pyridinyl)methyl 4-piperidinyl ether | C17H19ClN2O | 详情 | 详情 | |
(V) | 67055 | (1S,2R)-2-isopropyl-5-methylcyclohexyl 4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate | C31H43ClN2O3 | 详情 | 详情 | |
(VI) | 67056 | (S)-2-(((benzyloxy)carbonyl)amino)succinic acid | C12H13NO6 | 详情 | 详情 | |
(VIII) | 67058 | (2R,5R)-2-isopropyl-5- methylcyclohexyl 4-(4-((S)-(4-chlorophenyl)(pyridin-2 -yl)methoxy)piperidin-1-yl)butanoate | C31H43ClN2O3 | 详情 | 详情 | |
(IX) | 67059 | C21H25ClN2O3 | 详情 | 详情 |
合成路线4
【1】 Zhan ZQ, Zhou ZY, Peng LZ. 2006. Asymmetry synthesis of bepotastine besilate. Zhongguo Yiyao Gongye Zazhi, 37(11): 726~727. Krueger W, Krueger G. 1983. 4-[1-methyl-5-bis[(2-chloroethyl) amino] -2-benzimidazolyl] butyric acid. Ger, (East)DD 159877. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 57809 | 4-(4-Chlorobenzoyl)pyridine; 4-Chlorophenyl 4-pyridyl ketone | 14548-48-2 | C12H8ClNO | 详情 | 详情 |
(II) | 67060 | (S)-(4-chlorophenyl)(pyridin-2-yl)methanol | C12H10ClNO | 详情 | 详情 | |
(III) | 67061 | ethyl 3-(4-bromopiperidin-1-yl)propanoate | C10H18BrNO2 | 详情 | 详情 | |
(IV) | 22443 | ethyl 4-(4-[[(S)-(4-chlorophenyl)(2-pyridinyl)methyl]oxy]-1-piperidinyl)butanoate | C23H29ClN2O3 | 详情 | 详情 | |
(V) | 67062 | C21H25ClN2O3 | 详情 | 详情 |